Cohance Lifesciences Limited has informed the Exchange regarding Change in Director(s) of the company.
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cohance Lifesciences Limited has informed NSE about a change in its Board of Directors. The specific details of the change — including which director(s) are involved, whether it is a resignation, appointment, or both, and the effective date — are not fully disclosed in the headline. Shareholders would need to refer to the full filing or company's intimation letter for complete information on the nature of the change.
Director changes can affect governance continuity and board composition, but without details on the nature of the change, it is too early to assess the impact on the stock or shareholders. Investors should watch for further details on whether this is a routine change or a significant leadership shift.